Figure 2
(a) Crystals of xylanase obtained in condition 93 of part B (20% Jeffamine M2070, 20% dimethyl sulfoxide). (b) Crystals of streptavidin core obtained in condition 22 of part B (5% polyacrylate 2100, sodium salt). (c) Lysozyme crystals obtained in condition 38 of part C (35% Sokalan HP 56, 0.1 M bis-tris pH 5.5). (d) Lysozyme crystals obtained in condition 13 of part C (30% Sokalan CP 42, 0.2 M potassium acetate). (e) Crystals of the four MBT repeats of Sfmbt from D. melanogaster obtained in condition 96 of part A (35% polyacrylate 2100, sodium salt, 0.2 M ammonium sulfate, 0.1 M HEPES pH 7.5). (f) Crystals of spliceosomal assembly complex (SAC) 9 obtained in condition 41 of part C (25% Sokalan CP 42, 10% tetrahydrofuran, 0.1 M Tris final pH 7.0). (g) Crystals of spliceosomal assembly complex (SAC) 7 obtained in condition 21 of part B (6% polyvinyl pyrrolidone K15, 0.1 M HEPES pH 6.5). (h) Crystals of the cytokine receptor–ligand complex obtained in condition 44 of part A [45% pentaerythritol propoxylate (5/4 PO/OH), 0.2 M sodium chloride, 0.1 M MES pH 6.0]. |